Western Drug Recalls Medroxyprogesterone Injection Due to Sterility Concerns
Western Drug Inc. is recalling 17 containers of Medroxyprogesterone 150/LID 5 mg/mL Injection because the company cannot ensure the product is sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric. The hazard involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of infection or other adverse health consequences.
Plain-English summary
Western Drug Inc. is recalling 17 containers of Medroxyprogesterone 150/LID 5 mg/mL Injection. The recall was initiated because the company lacks assurance of the product's sterility. The affected product is a prescription medication distributed nationwide in the United States, specifically in Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah.
The recall covers all lots of the product. No specific lot numbers or expiration dates are provided in the source text. The product was distributed to healthcare providers and pharmacies in the listed states.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or pharmacist for further instructions. They should return the product to the pharmacy or healthcare provider where it was obtained.
The recalled product
- Product
- Medroxyprogesterone 150/LID 5 mg/mL Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938
- Manufacturer
- Western Drug
- Category
- Drug — Injectable Medication
- Affected units
- 17
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Part of a larger recall action
This product is one of 91 recalled by Western Drug under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 91 products in this recall →Related recalls
Same manufacturer · Western Drug
See all →- SevereWestern Drug Recalls Sodium Hydroxide 10% Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Benadryl Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls PZI 40 Insulin Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Ketorolac Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereGreen Valley Drugs Recalls Medroxyprogesterone Acetate Injection for Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereMoses Lake Pharmacy Recalls Medroxyprogesterone Acetate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMedroxyprogesterone Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereGuardian Pharmacy Recalls Medroxyprogesterone Vials Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- HighMedroxyprogesterone Acetate Injectable Suspension Recalled for Sterility Concerns
FDA (Drugs) · 2022-06-22
- SevereMedroxyprogesterone Acetate Injection Recalled for Sterility Assurance
FDA (Drugs) · 2022-02-09